Featured Research

from universities, journals, and other organizations

EPO doping helps combat cerebral malaria

Date:
April 21, 2011
Source:
University of Copenhagen
Summary:
Researchers have now discovered that EPO, the doping drug known from professional cycling, can significantly reduce cerebral malaria related deaths.

Almost 3.3 billion people, half of the world's population, risk being infected with malaria. Despite having effective means against malaria, the WHO reports 250 million cases of malaria each year and more than 700,000 related deaths. Researchers at the University of Copenhagen have now discovered that EPO, the doping drug known from professional cycling, can significantly reduce cerebral malaria related deaths.

Related Articles


When more than 700,000 people die from malaria each year it is due to two grave complications, which the malaria parasites manage to cause before they are eliminated by malaria drugs: Cerebral malaria and serious anemia. These two complications are the cause of almost every malaria-related death, with children between one and five years old being especially vulnerable. Cerebral malaria is responsible for half of all malaria related deaths.

Testing new treatment strategies

At the University of Copenhagen, the research team Pathogenesis from the Centre for Medical Parasitology (CMP) is working on ways to supplement the current malaria treatment with new medical preparations. The researchers are therefore investigating why these two complications have lethal consequences and how we can prevent this from happening. The researchers have, among other things, discovered that the doping drug EPO reduces cerebral malaria related deaths remarkably among test animals. The team is now working on ways to test this and other treatment strategies.

"EPO is an active molecule in the brain where it can protect the brain cells from damage and disease," explains Doctor Jψrgen Kurtzhals, associate professor at the CMP. EPO is naturally produced in the kidneys from where it sends signals to the bone marrow to produce more red blood corpuscles. But it is also produced in a number of other tissues for example the brain.

"We still do not have a treatment against cerebral malaria and we lack understanding of how the disease emerges, even though the parasite does not cross the blood-brain barrier and remains in the path of blood," says Kurtzhals.

EPO protects the brain

Researchers have found that children with high levels of EPO in their cerebrospinal fluid have less risk of dying from brain malaria.

"Our laboratory team has studied whether we can treat mice, which are infected with cerebral malaria, with EPO and the results are striking. The risk of dying drops from 100 percent to nearly 0," says Kurtzhals, who also points out that EPO does not remove the parasite from the blood.

"It is still necessary to treat a malaria infection with the current drugs, but EPO can be part of the treatment because it protects the brain while the malaria drugs kill the parasite."

Doctor Jψrgen Kurtzhals and his group are now working behind the microscopes to understand the exact molecular mechanisms, which enable EPO to protect the brain from damage of brain malaria. Other laboratories around the world are now testing EPO on malaria patients.

"We know EPO increases the number of red blood cells and their content of the red protein hemoglobin, and this increases the amount of oxygen that can be transported to the body's tissue and cells. This is the effect some athletes and professional cyclists abuse by increasing the outcome of each breath. But besides this effect, EPO also increases the level of hemoglobin in other cells, and this could be the reason why it protects brain cells against brain malaria," says Kurtzhals.

The Pathogenesis team at CMP focuses on how to improve the handling of malaria, while the world awaits an effective vaccine. The group's work ranges from basic research in parasitology and pathogenese to clinical trials with new drugs.


Story Source:

The above story is based on materials provided by University of Copenhagen. Note: Materials may be edited for content and length.


Cite This Page:

University of Copenhagen. "EPO doping helps combat cerebral malaria." ScienceDaily. ScienceDaily, 21 April 2011. <www.sciencedaily.com/releases/2011/04/110421104504.htm>.
University of Copenhagen. (2011, April 21). EPO doping helps combat cerebral malaria. ScienceDaily. Retrieved January 29, 2015 from www.sciencedaily.com/releases/2011/04/110421104504.htm
University of Copenhagen. "EPO doping helps combat cerebral malaria." ScienceDaily. www.sciencedaily.com/releases/2011/04/110421104504.htm (accessed January 29, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, January 29, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Are We Winning The Fight Against Ebola?

Are We Winning The Fight Against Ebola?

Newsy (Jan. 29, 2015) — The World Health Organization announced the fight against Ebola has entered its second phase as the number of cases per week has steadily dropped. Video provided by Newsy
Powered by NewsLook.com
Measles Scare Sends 66 Calif. Students Home

Measles Scare Sends 66 Calif. Students Home

AP (Jan. 29, 2015) — Officials say 66 students at a Southern California high school have been told to stay home through the end of next week because they may have been exposed to measles and are not vaccinated. (Jan. 29) Video provided by AP
Powered by NewsLook.com
Group Encourages Black Moms to Breastfeed

Group Encourages Black Moms to Breastfeed

AP (Jan. 29, 2015) — A grassroots effort is underway in several US cities to encourage more black women to breastfeed their babies by teaching them the benefits of the age-old practice, which is sometimes shunned in African-American communities. (Jan. 29) Video provided by AP
Powered by NewsLook.com
Sugary Drinks May Cause Early Puberty In Girls, Study Says

Sugary Drinks May Cause Early Puberty In Girls, Study Says

Newsy (Jan. 28, 2015) — Harvard researchers found that girls who consumed more than 1.5 sugary drinks a day had their first period earlier than those who drank less. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins